204 results
6-K
EX-99.1
REPCF
RepliCel Life Sciences Inc.
20 Mar 24
RepliCel announces a Letter of Intent for Asset Purchase Agreement
4:38pm
Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
3 | Page
6-K
EX-99.1
REPCF
RepliCel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
of the Company have been prepared by and are the responsibility of the Company's management.
The Company's independent auditor has not performed a review
6-K
EX-99.1
REPCF
RepliCel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
of the Company have been prepared by and are the responsibility of the Company's management.
The Company's independent auditor has not performed a review
6-K
EX-99.1
REPCF
RepliCel Life Sciences Inc.
19 Oct 23
Current report (foreign)
1:45pm
Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
3 | Page
6-K
EX-99.1
REPCF
RepliCel Life Sciences Inc.
4 Oct 23
RepliCel Provides Default Status Update and Announces Shareholder Approval of Equity Incentive Plan
2:23pm
.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
3 | Page
6-K
EX-99.2
c9dc46 5idrg
13 Sep 23
RepliCel Announces DermaPreciseā¢ Development Milestone, Updates Arbitration Proceedings
5:32pm
6-K
EX-99.1
k5r56by65jl2 4iy9
13 Sep 23
RepliCel Announces DermaPreciseā¢ Development Milestone, Updates Arbitration Proceedings
5:32pm
6-K
EX-99.1
mgysvqoe2f5zjf5
7 Sep 23
Current report (foreign)
12:26pm
6-K
EX-99.2
rsybi7i
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
6-K
EX-99.1
cf40kc9
29 Aug 23
RepliCel announces the passing of long time Chief Financial Officer Simon Ma; David Kwok is appointed Chief Financial Officer
1:14pm
6-K
EX-99.2
x5xn6jvqiwtz
17 Aug 23
Annual General and Special Meeting
11:22am
6-K
EX-99.4
6ue37wqzdosahp d4
17 Aug 23
Annual General and Special Meeting
11:22am
6-K
EX-99.1
cx9he3 fa06
9 Aug 23
Statement of Executive Compensation
7:41pm
6-K
EX-99.1
xuymt4co5iwy
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.1
q206fsc7w8ekdm
18 May 23
RepliCel Applies to Extend Warrant and Stock Option Expiry Dates and Announces Grant of Stock Options
1:58pm
6-K
EX-99.5
pwczl4
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
xxj 50z3jthzd
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
0bv630c700b 04cja5
25 Oct 22
Current report (foreign)
12:27pm
6-K
EX-99.2
c1jq3i9wkqq
25 Oct 22
Current report (foreign)
12:27pm